Senators Seek “Fresh” Ideas To Fight Health Fraud From Stakeholders
This article was originally published in The Pink Sheet Daily
An open letter to the “health care community” from a bipartisan group of senators on the Finance Committee asks for white papers offering suggestions on the best ways to combat “the multi-billion dollar problem” of waste, fraud and abuse in Medicare and Medicaid.
You may also be interested in...
A number of topical issues will be investigated by the HHS Office of Inspector General, according to its work plan for fiscal year 2013. Pharma industry issues are concentrated in the Medicare and Medicaid space.
Wholesale drug distributor McKesson settles charges that it reported inflated average wholesale prices (AWPs) for a large number of branded prescription pharmaceuticals, leading to extensive overpayments by the Medicaid program.
CMS mandates that Part D plans offer prescriptions filled for less than a 30-day period at a daily cost-sharing rate, with a few stated exceptions, but delays implementation until the 2014 plan year.